On August 1, 2022, analyst firm Barclays released its latest price target for Pfizer (NYSE:PFE) stock at $52.00 for the next 12 months. Over the past year, 19 analyst firms have published forecasts for Pfizer (NYSE:PFE) stock. Analysts assigned the stock a “neutral” rating. The average target price is $52.20 over the next 12 months. See the table below for the latest target prices and forecasts.